Switch Therapeutics: Funding, Investors & Team (Sep 2026)
Switch Therapeutics is a company in the field of biotechnology that creates therapeutic treatments utilizing RNAi technology. Founded in the year 2020, this company is situated in San Francisco, California, in the United States.
Switch Therapeutics has raised $52.0M across 1 funding round on record, the most recent a Series A of $52.0M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Switch Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Switch Therapeutics Funding Rounds
Switch Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Switch Therapeutics Funding Compared to Other Biotechnology Startups
Switch Therapeutics' latest round of $52.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Switch Therapeutics in Biotechnology and San Francisco
Companies Similar to Switch Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Switch Therapeutics Funding FAQs
What does Switch Therapeutics do?
Switch Therapeutics is a company in the field of biotechnology that creates therapeutic treatments utilizing RNAi technology. Founded in the year 2020, this company is situated in San Francisco, California, in the United States.
How much funding has Switch Therapeutics raised?
Switch Therapeutics has raised $52.0M across 1 round on record. The most recent is a Series A of $52.0M announced in Mar 2023.
When did Switch Therapeutics last raise funding?
Switch Therapeutics' most recent funding round on record is a Series A of $52.0M, announced in Mar 2023.
Who founded Switch Therapeutics?
FundedIQ lists Si Ping Han (Founder) at Switch Therapeutics.
Where is Switch Therapeutics headquartered?
Switch Therapeutics is based in San Francisco, California, United States.
How many employees does Switch Therapeutics have?
Switch Therapeutics is in the 11-50 employee band.
How does Switch Therapeutics' funding compare to other Biotechnology startups?
Switch Therapeutics' latest round of $52.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Switch Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Switch Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.